Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections.
about
Ocular cytochrome P450s and transporters: roles in disease and endobiotic and xenobiotic dispositionNovel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability.Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability.Predicting chemical ocular toxicity using a combinatorial QSAR approachTransporter-targeted lipid prodrugs of cyclic cidofovir: a potential approach for the treatment of cytomegalovirus retinitis.Pharmacokinetics of heroin and its metabolites in vitreous humor and blood in a living pig model.Ocular microdialysis: a continuous sampling technique to study pharmacokinetics and pharmacodynamics in the eye.Novel strategies for anterior segment ocular drug delivery.Nanotechnology approaches for ocular drug delivery.Liposomes in topical ophthalmic drug delivery: an update.A comprehensive insight on ocular pharmacokinetics.Transfected MDCK cell line with enhanced expression of CYP3A4 and P-glycoprotein as a model to study their role in drug transport and metabolism.Ocular sustained release nanoparticles containing stereoisomeric dipeptide prodrugs of acyclovir.Enhanced corneal absorption of erythromycin by modulating P-glycoprotein and MRP mediated efflux with corticosteroidsAmino Acids in the Development of Prodrugs
P2860
Q26851574-2783ADF9-36F1-433B-9D7F-0BC934CDDEBFQ33557899-19C4D5CF-6E44-48E2-A893-36DC487CF122Q33558455-4F2494CB-7039-4590-B890-A6AAD6316E6BQ34475745-83A18332-03B0-45C1-9988-BE05B11C69A8Q35892584-98DAE653-B6CD-4D71-A3FB-ACA6E310888CQ37245923-C8E86BD1-80FA-4456-947A-E341CBEFCDEBQ37810236-4095A225-C0FA-4208-99BE-D04FB7EE6688Q38065184-E772098D-A7C2-4901-BC99-883790D89D6BQ38098509-5A994386-60B0-4DCA-B432-3284372AAB1DQ38239330-1C620871-918A-49D7-BC8C-83312B095591Q38995367-51D8D00C-3861-43FB-9C2F-5569ECA660CFQ39335333-74F46B70-4320-4A36-8EA3-A61785049A25Q39557119-5A123B25-1629-466A-94D7-57D8961ABDFFQ39923954-B95F10CE-532A-4571-8FA8-381CB32BAF87Q58696356-07D37F24-D220-44F1-96D2-CF6BD18BDAA7
P2860
Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Ocular pharmacokinetics of acy ...... reating ocular HSV infections.
@en
Ocular pharmacokinetics of acy ...... reating ocular HSV infections.
@nl
type
label
Ocular pharmacokinetics of acy ...... reating ocular HSV infections.
@en
Ocular pharmacokinetics of acy ...... reating ocular HSV infections.
@nl
prefLabel
Ocular pharmacokinetics of acy ...... reating ocular HSV infections.
@en
Ocular pharmacokinetics of acy ...... reating ocular HSV infections.
@nl
P2093
P2860
P1476
Ocular pharmacokinetics of acy ...... reating ocular HSV infections.
@en
P2093
Ashim K Mitra
Sriram Gunda
Sudharshan Hariharan
Suresh Katragadda
P2860
P356
10.1016/J.IJPHARM.2008.03.015
P407
P577
2008-03-22T00:00:00Z